MentionFox
Home › funding signals › NeuroVice, Inc.
Form D · on the record

NeuroVice — $270K Form D filing, June 2025

NeuroVice, Inc. filed a Form D with the Securities and Exchange Commission on 2025-06-20.

NeuroVice, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 20, 2025. The filing reports $270K sold. Its industry group is Other Health Care. It names ASHLYN SANDERS (Executive Officer, Director), JORDAN SCHINDLER (Executive Officer) (SEC Form D, June 20, 2025).

5 more Other Health Care raises in North Carolina within 90 days ↓

Is this your company?

Key facts

Run the free check on NeuroVice, Inc. →

Sell to companies like NeuroVice, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

NeuroVice, Inc.

New Form D on file · 2025-06-20 · the record

$270K
raise on the record
D
filing
5
investors in
NORTH CAROLINA
based
Open the record →

What the record says

FilingForm D
Filed2025-06-20
Industry groupOther Health Care
Entity typeCorporation
Incorporated inDELAWARE
Year formed2025
BasedCHARLOTTE, NORTH CAROLINA
CIK2073574
Accession0002073574-25-000001

Pitching, partnering or investing alongside them? See who really runs and owns NeuroVice, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind NeuroVice, Inc., from the filings we hold.

More raises like this

Other Health Care raises by companies based in North Carolina, filed within 90 days of this one, largest first.

What do you want to do with NeuroVice, Inc.?

Get the full cited report on NeuroVice, Inc.

What the filing shows about NeuroVice, Inc.

  • 5 investors had already put money in when it filed.
  • The filing names 2 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on NeuroVice, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives NeuroVice, Inc.'s address as 1235 East Blvd Suite E, Pmb 2001, Charlotte, NC 28203.

What the filing says

  • Offered: $3,000,000. Sold: $270,000. Left to sell: $2,730,000. (filing)
  • Investors: 5 had already invested. (filing)
  • Date of first sale: May 5, 2025. (filing)
  • Types of securities: Options, warrants or other rights to acquire another security. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. It adds: “None other than payments of salary in the ordinary course of business to the parties named in Item 3.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on NeuroVice, Inc. See pricing

Is NeuroVice, Inc. a real, registered company?

NeuroVice, Inc. is a registered filer with the SEC (CIK 2073574) and has filed since 2025-06-20. 1 filing is on record, the latest on 2025-06-20.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs NeuroVice, Inc.?

NeuroVice, Inc.'s Form D of 2025-06-20 names ASHLYN SANDERS and JORDAN SCHINDLER as its officers, directors or promoters.

How much has NeuroVice, Inc. raised?

Its new offerings report $270K sold across 1 offering, as its own filings state.

Other Health Care · by week

Trailing twelve months. 869 filings in Other Health Care, totalled by week.

Want the whole picture on NeuroVice, Inc.?

What the filing shows about NeuroVice, Inc.

  • 5 investors had already put money in when it filed.
  • The filing names 2 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on NeuroVice, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on NeuroVice, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind NeuroVice, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for NeuroVice, Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

NeuroVice, Inc.: Raised $270K, Form D filed 2025-06-20
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/neurovice-inc-form-d-25000001
Last updated 2026-11-01
Primary record: SEC filing 1 · SEC filing 2
NeuroVice raised $270K — SEC Form D filing, June 2025. MentionFox, 2026-11-01. https://mentionfox.com/funding/neurovice-inc-form-d-25000001